Website: N/A
Stock Symbol: NASDAQ: KNDL
Market Value: N/A (in millions)
Kendle International Inc., an Ohio corporation established in 1989, is a global
clinical research organization (CRO) that provides a broad range of Phase I-IV
global clinical development services to the biopharmaceutical industry. The
Company augments the research and development activities of biopharmaceutical
companies by offering high-quality, value-added clinical research services and
proprietary information technology designed to reduce drug development time and
expense. The Company is managed in two reportable segments, Early Stage and Late
Stage. The Early Stage business currently focuses on the Company’s Phase I
operations, while Late Stage is comprised of clinical development services
related to Phases II through IV.